Passport for Care: A Useful Resource for the Delivery of Care to Childhood Cancer Survivors
This activity has been archived and credit is no longer available.
Visit the Passport for Care here.
Over 80% of childhood cancer patients become survivors of childhood cancer. However, survivors may be at risk for long-term late effects of their treatments with chemotherapy, radiation, surgery, and other modalities. Over time, therapy has been modified to reduce the late effects by using more intensified approaches for those at greatest risk and lessening therapeutic applications where that can be done. However, even survivors treated over the last two decades may be at risk for serious or life-threatening late effects. While excellent, comprehensive guidelines have been developed by the NIH-supported Children’s Oncology Group, their application can be challenging to implement in the clinic, particularly when clinicians may not have access to a survivorship care plan for the survivor listing the history of treatment exposures. The Passport For Care (PFC) is a clinical decision support tool, that is freely available to clinicians and to survivors themselves and makes available a survivorship care plan and guideline-based recommendations tailored to the survivor’s history of treatment exposure. This module introduces to clinicians the PFC, its benefits, and how it may be used to guide follow-up screening for late effects of cancer treatment.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
Over 80% of childhood cancer patients become survivors of childhood cancer. However, survivors may be at risk for long-term late effects of their treatments with chemotherapy, radiation, surgery, and other modalities. Over time, therapy has been modified to reduce the late effects by using more intensified approaches for those at greatest risk and lessening therapeutic applications where that can be done. However, even survivors treated over the last two decades may be at risk for serious or life-threatening late effects. While excellent, comprehensive guidelines have been developed by the NIH-supported Children’s Oncology Group, their application can be challenging to implement in the clinic, particularly when clinicians may not have access to a survivorship care plan for the survivor listing the history of treatment exposures. The Passport For Care (PFC) is a clinical decision support tool, that is freely available to clinicians and to survivors themselves and makes available a survivorship care plan and guideline-based recommendations tailored to the survivor’s history of treatment exposure. This module introduces to clinicians the PFC, its benefits, and how it may be used to guide follow-up screening for late effects of cancer treatment.
Educational Objectives
At the conclusion of the conference, participants should be able to:
- Discuss the frequency of and source of risks facing long-term survivors of childhood cancer.
- Describe the role for survivorship care plans in screening for late effects of cancer treatments.
- Articulate how a clinical decision support tool can support delivering care in alignment with national guidelines.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Oncology
- Pediatrics
Interest Groups
- Hospital Medicine
- Primary Care
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
-
Michael Fordis, M.D.
Senior Associate Dean and Director, Center for Collaborative and Interactive Technologies (CCIT)
Baylor College of Medicine
Term of Approval
April 1, 2022 through March 31, 2024. Original release date: April 2022
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Maria Gramatges, M.D.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Activity Director
-
Michael Fordis, M.D.
Senior Associate Dean and Director, Center for Collaborative and Interactive Technologies (CCIT)
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Michael Fordis, M.D.
Senior Associate Dean and Director, Center for Collaborative and Interactive Technologies (CCIT)
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Maria Gramatges, M.D.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
-
David Poplack, M.D.
Professor, Elise C. Young Chair in Pediatric Oncology
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: